MCP-1 induces tumorigenesis of breast cancer by stimulating epithelial-mesenchymal transition (EMT) and cell migration, which are mediated by the ERK/GSK-3β/Snail pathway [28]. The gene discussed is CCL2; the disease is breast carcinoma.